Guardion Health Sciences, Inc. (NASDAQ:GHSI – Get Free Report) was the target of a large decrease in short interest during the month of August. As of August 15th, there was short interest totalling 55,600 shares, a decrease of 5.1% from the July 31st total of 58,600 shares. Based on an average daily trading volume, of 41,700 shares, the short-interest ratio is currently 1.3 days. Currently, 5.5% of the shares of the company are sold short.
Guardion Health Sciences Stock Up 5.8 %
NASDAQ GHSI opened at $14.67 on Wednesday. The company has a market capitalization of $18.78 million, a P/E ratio of -3.65 and a beta of 0.91. Guardion Health Sciences has a 12-month low of $5.01 and a 12-month high of $18.00. The firm has a 50-day moving average price of $10.34 and a two-hundred day moving average price of $9.28.
Guardion Health Sciences Announces Dividend
The firm also recently disclosed a dividend, which will be paid on Monday, September 23rd. Shareholders of record on Monday, September 9th will be issued a $5.00 dividend. The ex-dividend date of this dividend is Monday, September 9th.
Guardion Health Sciences Company Profile
Guardion Health Sciences, Inc, a clinical nutrition company, develops and distributes clinically supported dietary supplements and medical foods in North America, Europe, and internationally. The company offers GlaucoCetin, a dietary supplement to support mitochondrial function with additional antioxidants to help reduce oxidative stress and increase blood flow throughout the body for enhanced eye support and ocular health; and Lumega-Z, a medical food that replenishes and restores the macular protective pigment.
Read More
- Five stocks we like better than Guardion Health Sciences
- How to Calculate Return on Investment (ROI)
- 3 Small Cap Stocks That Insiders Are Buying
- Conference Calls and Individual Investors
- Analysts Forecast Big Upside for Western Digital—Don’t Miss Out
- What is Insider Trading? What You Can Learn from Insider Trading
- 3 Must-Own Stocks for Bullish Investors in Today’s Market
Receive News & Ratings for Guardion Health Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Guardion Health Sciences and related companies with MarketBeat.com's FREE daily email newsletter.